Topics
Guillain-Barré syndromeDisease
This review provides an update on the current understanding of the pathogenesis of Guillain-Barré syndrome (GBS). Progress has been made in elucidating relevant pathomechanisms, especially in the axonal variants of the disease. However, the precise target autoantigens still need to be determined. Future therapeutic approaches and currently available strategies are critically discussed
Copyright © 2014 J. B. Winer. This is an open access article distributed under the Creative Commons ...
Background: Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy with a heterogeneous p...
This presentation highlights aspects of the immunobiology of the Guillain-Barré syndromes (GBS), the...
Guillain-Barré syndrome (GBS) was first described in 1916 (Guillain G, 1916) and is approaching its ...
Guillain-Barré syndrome is the most common and most severe acute paralytic neuropathy, with about 10...
Guillain-Barré syndrome (GBS) is an acute, immune-mediated polyneuropathy that usually follows an an...
Guillain–Barré syndrome (GBS) is an infrequent acute paralytic polyneuropathy that impacts around on...
The term Guillain–Barré syndrome (GBS), the most frequent cause of acute paralytic neuropathy, cover...
The clinical entity of Guillain-Barr6-Syndrome (GBS) comprises of at least four subtypes of peripher...
The first case of Guillain-Barré syndrome was described in 1916. Since then, knowledge about the pat...
J O U R N A L Neurons: A Peer-reviewed International Neuroscience Journal ISSN: 2348-3237 | Pub...
Guillain-Barré syndrome (GBS) is an autoimmune and post-infectious immune disease. The syndrome incl...
Guillain-Barre syndrome is the most common and most severe acute paralytic neuropathy, with about 10...
Guillain–Barré Syndrome is an autoimmune disease that leaves up to 20 percent of patients severely ...
Guillain-Barré Syndrome is a life-threatening, demyelinating, autoimmune condition in which the body...
Copyright © 2014 J. B. Winer. This is an open access article distributed under the Creative Commons ...
Background: Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy with a heterogeneous p...
This presentation highlights aspects of the immunobiology of the Guillain-Barré syndromes (GBS), the...
Guillain-Barré syndrome (GBS) was first described in 1916 (Guillain G, 1916) and is approaching its ...
Guillain-Barré syndrome is the most common and most severe acute paralytic neuropathy, with about 10...
Guillain-Barré syndrome (GBS) is an acute, immune-mediated polyneuropathy that usually follows an an...
Guillain–Barré syndrome (GBS) is an infrequent acute paralytic polyneuropathy that impacts around on...
The term Guillain–Barré syndrome (GBS), the most frequent cause of acute paralytic neuropathy, cover...
The clinical entity of Guillain-Barr6-Syndrome (GBS) comprises of at least four subtypes of peripher...
The first case of Guillain-Barré syndrome was described in 1916. Since then, knowledge about the pat...
J O U R N A L Neurons: A Peer-reviewed International Neuroscience Journal ISSN: 2348-3237 | Pub...
Guillain-Barré syndrome (GBS) is an autoimmune and post-infectious immune disease. The syndrome incl...
Guillain-Barre syndrome is the most common and most severe acute paralytic neuropathy, with about 10...
Guillain–Barré Syndrome is an autoimmune disease that leaves up to 20 percent of patients severely ...
Guillain-Barré Syndrome is a life-threatening, demyelinating, autoimmune condition in which the body...
Copyright © 2014 J. B. Winer. This is an open access article distributed under the Creative Commons ...
Background: Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy with a heterogeneous p...
This presentation highlights aspects of the immunobiology of the Guillain-Barré syndromes (GBS), the...
Add to ORKG